Biomedicines (May 2022)

Current Development of Nano-Drug Delivery to Target Macrophages

  • Donglin Cai,
  • Wendong Gao,
  • Zhelun Li,
  • Yufeng Zhang,
  • Lan Xiao,
  • Yin Xiao

DOI
https://doi.org/10.3390/biomedicines10051203
Journal volume & issue
Vol. 10, no. 5
p. 1203

Abstract

Read online

Macrophages are the most important innate immune cells that participate in various inflammation-related diseases. Therefore, macrophage-related pathological processes are essential targets in the diagnosis and treatment of diseases. Since nanoparticles (NPs) can be preferentially taken up by macrophages, NPs have attracted most attention for specific macrophage-targeting. In this review, the interactions between NPs and the immune system are introduced to help understand the pharmacokinetics and biodistribution of NPs in immune cells. The current design and strategy of NPs modification for specific macrophage-targeting are investigated and summarized.

Keywords